News Releases Archives

Drug Discovery News

by MT Molecular | Oct 25, 2014

Drug Discovery News Biotek Scientific Director likes Montana Molecular’s live cell assays: “These sensors can be used for the simultaneous detection of all these second messengers. That is something that is really unique and really powerful, specifically for...

PHASE II SBIR Funding Awarded to Montana Molecular

by MT Molecular | Apr 9, 2014

$1.1 million investment from the National Institutes of Health advances next generation tools for drug discovery in living cells. Montana Molecular, a privately-held company developing next generation tools for drug discovery in living cells, has been awarded a Phase...

DAG sensor and μ-opioid receptor desensitization

by MT Molecular | Apr 9, 2014

DAG sensor and μ-opioid receptor desensitization Early adopters of Montana Molecular’s DAG sensor at The Vollum Institute published new results in the British Journal of Pharmacology. This study made good use of our Upward DAG sensor for diacylglycerol to...

DAG sensor illuminates TRPC6 Regulation

by MT Molecular | Apr 9, 2014

Montana Molecular’s DAG sensor helped unravel the molecular mechanisms of TRPC6 cation channel activity which could lead to new treatments for TRPC6-associated diseases that affect cardiovascular and kidney dysfunction such as vasospasm and...

Wondering about BacMam in your favorite cell type?

by MT Molecular | Mar 20, 2014

BacMam technology is evolving and transduction efficiencies have improved substantially since many of these pioneering papers were published. This body of work provides a summary of what has been accomplished and a starting point for assay optimization in your cell...

Biotek and Montana Molecular Collaborate

by MT Molecular | Mar 17, 2014

Montana Molecular’s assays are ideal for measuring GPCR activity on Biotek’s fluorescence plate readers! In fact, we screen and optimize all of our fluorescent assays in-house on our Biotek Synergy MX. We were curious about the new Biotek Cytation 3...